Newsdeck

Kenya to Begin Manufacturing Covid-19 Vaccines to Ensure Supply

By Bloomberg 15 September 2021
Caption
Vials of Covishield, the local name for the Covid-19 vaccine developed by AstraZeneca Plc. and the University of Oxford, move along a conveyor on the production line at the Serum Institute of India Ltd. Hadaspar plant in Pune, Maharashtra, India, on Friday, Jan. 22, 2021. Serum, which is the world's largest vaccine maker by volume, has an agreement with AstraZeneca to produce at least a billion doses. Photographer: Dhiraj Singh/Bloomberg

(Bloomberg) --Kenya is establishing a fill-and-finish facility for Covid-19 vaccines ahead of setting up a full-scale manufacturing plant to guarantee supply.

By Eric Ombok
Sep 15, 2021, 10:56 AM
Word Count: 113

“We aim to start local production during the first quarter of 2022 and have a fully fledged human vaccine manufacturing capability by 2024,” according to the National Covid-19 Vaccine Deployment Plan published by the Ministry of Health.

Fill-and-finish facilities enable third parties to put ready-made vaccines into vials, seal and pack them for distribution.

The number of vaccination sites in Kenya will be increased to 3,000, from 800 currently, and the average number of daily inoculations will be doubled to 80,000 by month-end and increase to 150,000 by December, according to the plan.

© 2021 Bloomberg L.P.

Information pertaining to Covid-19, vaccines, how to control the spread of the virus and potential treatments is ever-changing. Under the South African Disaster Management Act Regulation 11(5)(c) it is prohibited to publish information through any medium with the intention to deceive people on government measures to address COVID-19. We are therefore disabling the comment section on this article in order to protect both the commenting member and ourselves from potential liability. Should you have additional information that you think we should know, please email [email protected]

Gallery

ROAD TO 2021 LOCAL ELECTIONS ANALYSIS

Voter anger at local state failure unlikely to be tempered by Ramaphosa’s charm offensive this time

By Ferial Haffajee

Fewer children in Seattle are vaccinated against polio than in Rwanda.